Articles
| Open Access |
https://doi.org/10.55640/
RISK FACTORS AND CLINICAL FEATURES OF RECURRENT BRONCHITIS IN CHILDREN
Azizova N. D.,1 Kabilova D. K.,2 Zokirov B. K.3 , 1.Republican Specialized Scientific and Practical Medical Center of Pediatrics of the Ministry of Health of the Republic of Uzbekistan, 2.Medical Faculty of the Central Asian Medical University. Fergana. 3.Andijan State Medical Institute.Abstract
Bronchopulmonary pathology in children includes acute and chronic diseases, among which a special place is occupied by recurrent obstructive bronchitis (ROB), which is a precursor to bronchial asthma. The study analyzed the clinical features and risk factors for the development of recurrent bronchitis in young children. The study included 90 children aged 3 months to 3 years, divided into two groups: with recurrent bronchitis and with recurrent bronchitis with broncho-obstruction. The main predisposing factors were identified, including perinatal complications, frequent respiratory infections, hereditary predisposition and allergic reactions. Clinical manifestations of broncho-obstruction were characterized by difficulty breathing, wheezing, cough and radiographic changes in the lungs. The study emphasizes the need for early detection and prevention of recurrent bronchitis in children with a high risk of developing bronchial asthma.
Keywords
broncho-obstructive syndrome, recurrent bronchitis, bronchial asthma, risk factors, pediatric pulmonology, respiratory infections.
References
Ахмедова Д.И., Ашурова Д.Т., Арифова Г.А. Факторы риска развития синдрома бронхиальной обструкции у детей раннего возраста // Ж. Педиатрия.- Т., 2019. - 2-3. - С. 52-53
Ашурова Д.Т. Клинико-иммунологическая характеристика синдрома бронхиальной обструкции у детей раннего возраста // Материалы 9 съезда педиатров России, Москва. - 2021. –С. 54.
Балаболкин, И.И. Атопия и аллергические заболевания у детей / И.И.Балаболкин // Педиатрия.–2022.
Германова О.Н. Клинико-иммунологические особенности обструктивного бронхита у детей с инфекциями респираторного тракта: автореф. дис. … канд. мед. наук / О.Н. Германова - Ставрополь, 2021.- 23 с.3.–№ 6.–С. 4-7, 99-102.
Даминов Т.А. Выявление группы риска по развитию бронхиальной астмы у детей и прогнозирование отдаленных последствий заболеваний с бронхообструктивным синдромом: Даминов Т.А., Халматова Б.Т., Сотиболдиева Н.Р. Инф.письмо (№8п/53).–Т.,2015.–4 с
Жукова О. В. Концепция факторов риска в оценке влияния "атипичных" возбудителей на формирование бронхиальной астмы у детей с острым и рецидивирующим обструктивным бронхитом : научное издание / О. В. Жукова // Российский медицинский журнал. - М., 2016. - Том 22 N2Р220162. - C. 77-81. - Библиогр.: 5 назв.
Pojsupap S., Iliriani K., Sampaio T. Z. A. L. Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis //Journal of Asthma. – 2021. – Т. 52. – №. 4. – С. 382-390.
Raissy, H. H. Benefits and Risks of Long-Term Asthma Management in Children: Where Are We Heading? // Drug safety. –2017. – Vol. 40, № 3. – P. 201-210.
Sarah, D. Regulatory T cells, inflammation and the allergic response. The role of glucocorticoids and Vitamin D/ D. Sarah [et al.]// The Journal of Steroid Biochemistry and Molecular Biology .-2020.-№120(2).-Р.86-95.
Ullmann N, Bossley CJ, Fleming L, Silvestri M, Bush A, Saglani S. Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma. Allergy (2023) 68:402–6.
Yong S. J. Body mass index and asthma in United States // Arch intern Med. – 2021. – Vol. 161, №13. – P. 1605-1611.
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.